Spero Therapeutics Inc (SPRO)
1.185
-0.06
(-5.20%)
USD |
NASDAQ |
Nov 15, 14:21
Spero Therapeutics Cash and Short Term Investments (Quarterly): 63.53M for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 63.53M |
| March 31, 2024 | 82.27M |
| December 31, 2023 | 76.33M |
| September 30, 2023 | 93.82M |
| June 30, 2023 | 77.69M |
| March 31, 2023 | 96.25M |
| December 31, 2022 | 109.11M |
| September 30, 2022 | 50.45M |
| June 30, 2022 | 45.40M |
| March 31, 2022 | 121.97M |
| December 31, 2021 | 146.40M |
| September 30, 2021 | 123.42M |
| June 30, 2021 | 99.22M |
| March 31, 2021 | 115.68M |
| December 31, 2020 | 126.91M |
| Date | Value |
|---|---|
| September 30, 2020 | 127.24M |
| June 30, 2020 | 71.36M |
| March 31, 2020 | 88.84M |
| December 31, 2019 | 82.04M |
| September 30, 2019 | 93.86M |
| June 30, 2019 | 103.41M |
| March 31, 2019 | 106.39M |
| December 31, 2018 | 115.44M |
| September 30, 2018 | 131.22M |
| June 30, 2018 | 66.64M |
| March 31, 2018 | 75.39M |
| December 31, 2017 | 87.29M |
| September 30, 2017 | 25.37M |
| June 30, 2017 | 36.30M |
| December 31, 2016 | 10.32M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
45.40M
Minimum
Jun 2022
146.40M
Maximum
Dec 2021
94.63M
Average
93.82M
Median
Sep 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| Arbutus Biopharma Corp | 127.79M |
| Equillium Inc | 33.30M |
| NovaBay Pharmaceuticals Inc | 0.776M |
| Palatin Technologies Inc | 9.527M |
| iBio Inc | 14.21M |